drugset / Trial / NCT00314756

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

NCT00314756

Phase 4 Completed 15 enrolled Wake Forest University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the efficacy of treating a nodular basal cell carcinoma with imiquimod cream after initial treatment with curettage

Timeline

Start
2005-03
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 5 % Topical

Indications